Registrations are open: join us in Hong Kong for the World Bladder Cancer Patient Forum 2026
Join the global bladder cancer community in Hong Kong this September: registrations for the World Bladder Cancer Patient Forum 2026 are now open.
WBCPC speaks on bladder cancer and continence health at EU policy event in Brussels
Following World Continence Week, our Project Coordinator Theodoros Yfantis represented the bladder cancer patient community at a high level event on continence health in EU policy, organised by the European Association of Urology.
Understanding BCG treatment: new patient factsheet available
Our new factsheet, “Understanding BCG treatment for bladder cancer” helps patients and carers understand this widely used immunotherapy for non-muscle-invasive bladder cancer and discuss it with their care team.
What nobody tells you: An opinion piece on bladder cancer, continence and the care that is missing
During World Continence Week 2026, Prof Bente Thoft Jensen, Prof Shingai Mutambirwa and patient advocate Alessandro Boni call on health systems worldwide to make continence a routine, not an afterthought, in bladder cancer care.
Bladder Cancer Burden Survey findings discussed at AUA2026
Our Executive Director Alex Filicevas and Dr Ashish Kamat, MD, Chair of the WBCPC Scientific Advisory Board, discussed findings from the Bladder Cancer Burden Survey at AUA2026, revealing the profound impact of treatment on the daily lives of people affected by bladder cancer.
Men’s Health Week 2026: Raising Awareness and Supporting Early Diagnosis
WBCPC marks Men’s Health Week 2026 by raising awareness of bladder cancer’s disproportionate impact on men and encouraging early diagnosis.
